Cocrystal Pharma filed an IND to proceed with US clinical trials, while the CDC estimated 685 million annual Norovirus cases.

The entities involved

• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
• Cocrystal Pharma →

  company in Bothell, United States

  • Cocrystal Pharma and Bristol-Myers Squibb are competing for investment as healthcare companies.Sun 22:20
• Centers for Disease Control →

  governmental medical research institute with headquarters in Taipei, Taiwan

  • Ebola outbreak forced the flight to seek refuge.Sat 23:58
  • The outbreak in the Democratic Republic of the Congo necessitates a coordinated response involving health agencies.Sat 21:44

Related events

• Ondine Biomedical Inc. is seeking a pre-NDA meeting with the FDA regarding LANTERN results while conducting clinical trials in the US and Canada.Sep 10
• The FDA placed a clinical hold on the IND application for the company Aardvark.Jul 30
• Capricor Therapeutics is seeking regulatory approval from the FDA for clinical trials and has listed on the Nasdaq stock exchange, with a law firm based in New York City involved.Aug 5
• Nkarta is seeking protocol amendments for its clinical trials under the FDA.Sun 19:56
• A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.Jun 7